Drug and Medicine Fill Finish

-


Drug and Medicine Fill Finish


AbbVie Contract Manufacturing aims to increase the global pharmaceutical capability through its fully integrated production facility that offers fill finish services, process development, and drug substance manufacturing. We offer a range of solutions in biologics development and manufacturing.

Our facility supplies biopharmaceutical products to meet growing manufacturing demands from global pharmaceutical companies. AbbVie Pharmaceutical Contract Manufacturing offers advanced cGMP facilities providing clinical and commercial products based on mammalian cell culture. 

All processes are cGMP-compliant and follow the guidelines of the U.S. FDA, EMA, and local authorities. Our dedication to quality and optimal services is visible in everything we do, from small-scale clinical trials to large-scale commercial manufacturing.


Drug Fill Finish


Drug producers need to constantly deliver on all these fronts and more, without undermining speed-to-market, to manage a successful pharmaceutical program. The direct benefits of pharmaceutical outsourcing and contract manufacturing allow developers to access both modern technology and accelerate the time to market.

1.Precise Drug Dosing: When making a new chemical entity, we ensure precise dosing and drug delivery as this is crucial for success. Regulatory agencies and clinicians want to see well-characterized, reliable doses with good bioavailability. Consumers also often opt for a controlled release dosage form, with simple packaging and taste-free consumption.

2.High Capacity Manufacturing Facilities: At AbbVie, we have biopharmaceutical manufacturing plants that accommodate stainless steel bioreactors with high capacities designed and built to carry rapid high protein production. We have suites for upstream, downstream, fill, and finish units, as well as long-term cold storage capacity.

3.Quality and Technical Capability: AbbVie Contract Manufacturing holds to the heart the highest levels of technical capability, quality, and regulatory compliance. We understand the complex nature of sterile manufacturing of biological drug products and we do not take this for granted on every project we undertake.

Medicine Fill Finish


As an active CMO, we are also flexible as regards offering our biotech and specialty pharmaceutical client’s quick access to manufacturing slots and fast QA batch releases.

1.Clinical Services: Our other services include clinical and commercial bulk current good manufacturing practice, manufacturing of drug substances and drug products. All these come with quality assurance, quality control, and regulatory compliance standards, and support for our dear customers.

2.Cell Line Generation: AbbVie biologics contract manufacturing offers services such as cell line generation, process and analytical method development and analytical services at its facilities.  With our solid network of experts, supply chains, and facilities across North America and Europe, we are here to extend your capabilities, efficiency and reach. 

AbbVie Contract Manufacturing provides biologics contract manufacturing using innovative filling line technologies that are specifically built to protect your biologic integrity and optimize your API yield. Our manufacturing optimization meets the needs of your biologic molecules with 100% in-line, constructive weight checking; high-yield process design; dual filling technologies, and advanced cold-chain filling.

Contact us today if you are planning a biological manufacturing project, or would like to find out more about our biologics manufacturing facilities. With our wealth of experience dealing with biologics, AbbVie Contract Manufacturing is competent across all areas of fill-finish manufacturing. 

Comments

Post a Comment

Popular posts from this blog

What Is Fill Finish? A Complete Guide to Pharmaceutical Manufacturing

-
Image
Learn what fill finish manufacturing is, how aseptic fill finish works, and why it’s critical for drug safety, sterility, and pharmaceutical quality. Fill Finish Manufacturing: A Complete Guide to Aseptic Drug Fill Finish There is a point in the life of almost every injectable medicine where the science is essentially done — the molecule is right, the formulation is stable, the clinical data is compelling. And then comes fill finish. It is the step most people outside the industry rarely think about, yet it is arguably where everything can go wrong. Fill finish is the process of taking a sterile drug substance and getting it safely into its final container — a vial, a pre-filled syringe, a cartridge, or a flexible bag — sealing it, and sending it to inspection before it ever reaches a patient. Simple to describe. Enormously complex to execute. And, for manufacturers of biologics or any other product that cannot withstand terminal sterilisation, it is the single most contamination-sensi...
Read more

Potent Drug Contract Manufacturing for Safe and Scalable Solid Dose Production

-
Image
Potent Drug Contract Manufacturing for Modern Solid Dose Manufacturing Pharma companies developing high-potency medicines depend on safe, efficient processes. This is where potent drug contract manufacturing   becomes essential. AbbVie supports these complex projects with advanced containment, strict compliance systems, and solid dose manufacturing capabilities designed for high-potency APIs. Introduction to Potent Drug Contract Manufacturing Handling potent APIs requires isolator systems, engineered airflow, and streamlined procedures that protect workers and ensure product quality. As more therapies involve high-potency ingredients, demand continues to grow for partners who can manage solid dose manufacturing with precision and reliability. AbbVie’s platform supports early formulation, scale-up, and full commercial production, giving teams confidence as they advance high-potency compounds through the development lifecycle. Benefits of Potent Drug Contract Manufacturing in Solid D...
Read more

Custom API: Tailored Active Ingredients for Pharma Innovation

-
Image
In the world of pharmaceuticals, one size rarely fits all. That’s where custom API solutions lead the way. Custom APIs—or custom active pharmaceutical ingredients —are the building blocks of targeted, high-performing therapies. These tailored molecules support specific treatment goals, regulatory needs, and delivery systems. Let’s explore why custom API development is key to pharmaceutical success—and how AbbVie helps you scale with precision. What Is a Custom API in Pharma? A custom API is a specially designed active pharmaceutical ingredient. Unlike generic APIs, it’s created with your exact drug formula and delivery system in mind. This means: Enhanced therapeutic performance Better bioavailability Improved patient compliance Stronger intellectual property protection At AbbVie, custom API development is more than synthesis—it's strategy, innovation, and execution. Why Custom Active Pharmaceutical Ingredients Matter In modern drug development, competition ...
Read more